Management Committee

The management committee supports BCCGN by providing guidance on strategic initiatives and important issues and opportunities that may affect the operations of the Network. Members were selected to broadly represent stakeholders and provide complimentary perspectives and expertise.

Jehannine Austin PhD CGC/CCGC
Assistant Professor, UBC Department of Psychiatry Centre for Complex Disorders and Consultant, Psychiatry, Child & Family Research Institute

Carlo Marra PHARM.D., PH.D., FCHSP
Director, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences
Research Scientist
Centre for Health Evaluation of Outcome Sciences
St Paul’s Hospital

Peter Pare MD
Department of Medicine, University of British Columbia;
iCAPTURE Center for Cardiovascular and Pulmonary Research

Laura Arbour MD, MSc, FRCPC
Associate Professor,
Medical Genetics, University of British Columbia;
Victoria General Hospital

Marco Marra PhD, FRSC
Genome Sciences Centre
BC Cancer Agency
Professor; UBC
Medical Genetics
Adjunct Professor, Molecular Biology and Biochemistry
Simon Fraser University

Brad Popovich MSc, PhD, FACMG
President and Chief Executive Officer, Sirius Genomics Inc

Sylvie Langlois, MD, FRCPC, FCCMG
Associate Professor
Medical Genetics, University of British Columbia; Children’s and Women’s Hospital

Brad McNeney Ph.D
Associate Professor
Statistics & Actuarial Science, Simon Fraser University

Stuart Turvey MB, BS, DPhil, FRCPC
Assistant Professor, University of British Columbia; Division of Infectious and Immunological Diseases, Department of Pediatrics, BC Children’s Hospital and Clinician Scientist, Pediatrics, Child & Family Research Institute

Michael S. Kobor Ph.D
Associate Professor, Department of Medical Genetics, University of British Columbia; Scientist, Centre for Molecular Medicine & Therapeutics and Scholar, Molecular Medicine and Therapeutics, Child & Family Research Institute

Brent Murray Ph.D
Associate Professor, Biology
Ecosystem Science and Management Program
University of Northern British Columbia

Lily Lau
Director of Finance
Centre for Molecular Medicine & Therapeutics